Related references
Note: Only part of the references are listed.Birth weight, breast cancer susceptibility loci, and breast cancer risk
Rulla M. Tamimi et al.
CANCER CAUSES & CONTROL (2010)
Distribution of FGFR2, TNRC9, MAP3K1, LSP1, and 8q24 alleles in genetically enriched breast cancer patients versus elderly tumor-free women
Tatiana V. Gorodnova et al.
CANCER GENETICS AND CYTOGENETICS (2010)
FGFR2 and other loci identified in genome-wide association studies are associated with breast cancer in African-American and younger women
Jill S. Barnholtz-Sloan et al.
CARCINOGENESIS (2010)
Breast cancer susceptibility variants alter risks in familial disease
Ayse Latif et al.
JOURNAL OF MEDICAL GENETICS (2010)
Common breast cancer-predisposition alleles are associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers
Antonis C. Antoniou et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2008)
Genetic Susceptibility Loci for Breast Cancer by Estrogen Receptor Status
Montserrat Garcia-Closas et al.
CLINICAL CANCER RESEARCH (2008)
Genome-wide association studies in cancer
Douglas F. Easton et al.
HUMAN MOLECULAR GENETICS (2008)
Discriminatory accuracy from single-nucleotide polymorphisms in models to predict breast cancer risk
Mitchell H. Gail
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)
Heterogeneity of breast cancer associations with five susceptibility loci by clinical and pathological characteristics
Montserrat Garcia-Closas et al.
PLOS GENETICS (2008)
A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer
David J. Hunter et al.
NATURE GENETICS (2007)
Genome-wide association study identifies novel breast cancer susceptibility loci
Douglas F. Easton et al.
NATURE (2007)
Genes harbouring susceptibility SNPs are differentially expressed in the breast cancer subtypes
Silje H. Nordgard et al.
BREAST CANCER RESEARCH (2007)
Activation of mitogen-activated protein kinase in estrogen receptor α-positive breast cancer cells in vitro induces an in vivo molecular phenotype of estrogen receptor α-negative human breast tumors
CJ Creighton et al.
CANCER RESEARCH (2006)
Oncogenic pathway signatures in human cancers as a guide to targeted therapies
AH Bild et al.
NATURE (2006)
Resveratrol and estradiol rapidly activate MAPK signaling through estrogen receptors α and β in endothelial cells
CM Klinge et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Share Paper
